K

Kyung Nam Pharm Co Ltd
KOSDAQ:053950

Watchlist Manager
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Watchlist
Price: 642 KRW -2.58%
Market Cap: ₩50.2B

Net Margin

-10%
Current
Declining
by 0.7%
vs 3-y average of -9.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-10%
=
Net Income
₩-5.7B
/
Revenue
₩57.4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-10%
=
Net Income
₩-5.7B
/
Revenue
₩57.4B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
50.2B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Lower than 79% of companies in Korea
Percentile
21st
Based on 2 632 companies
21st percentile
-10%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Kyung Nam Pharm Co Ltd
Glance View

Market Cap
50.2B KRW
Industry
Pharmaceuticals

Kyungnam Pharm Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Uiryeong-Gun, Gyeongsangnam-Do. The company went IPO on 2001-11-06. The firm's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The firm provides vitamin products under the brand name LEMONA. The company supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.

Intrinsic Value
812.96 KRW
Undervaluation 21%
Intrinsic Value
Price
K
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-10%
=
Net Income
₩-5.7B
/
Revenue
₩57.4B
What is Kyung Nam Pharm Co Ltd's current Net Margin?

The current Net Margin for Kyung Nam Pharm Co Ltd is -10%, which is below its 3-year median of -9.3%.

How has Net Margin changed over time?

Over the last 3 years, Kyung Nam Pharm Co Ltd’s Net Margin has decreased from -7% to -10%. During this period, it reached a low of -35.4% on Dec 31, 2023 and a high of 16.6% on Dec 31, 2024.

Back to Top